Similar articles for PMID: 28258910

Year	Number of Results
1993	2
2000	3
2001	1
2003	1
2004	1
2005	2
2006	2
2007	4
2008	2
2009	2
2010	4
2011	9
2012	11
2013	8
2014	15
2015	22
2016	17
2017	17
2018	15
2019	12
2020	5
2021	2
2022	2
2023	1
2024	0

1

[Prevalence and diversity of management of prostate cancer patients classified as low risk using D'Amico group or Cancer of the Prostate Risk Assessment (CAPRA) score: A French multicenter study].

Léon P, Cancel-Tassin G, Koutlidis N, Calves J, Funes de la Vega M, Fournier G, Valeri A, Cormier L, Larré S, Cussenot O. Léon P, et al. Prog Urol. 2017 Mar;27(3):158-165. doi: 10.1016/j.purol.2017.01.003. Epub 2017 Mar 1. Prog Urol. 2017. PMID: 28258910 French.

2

[Management of low-risk prostate cancer].

Rozet F, Bastide C, Beuzeboc P, Cormier L, Fromont G, Hennequin C, Mongiat-Artus P, Peyromaure M, Renard-Penna R, Richaud P, Salomon L, Soulié M; Les membres du comité de cancérologie de l’AFU. Rozet F, et al. Prog Urol. 2015 Jan;25(1):1-10. doi: 10.1016/j.purol.2014.10.007. Epub 2014 Nov 20. Prog Urol. 2015. PMID: 25454776 Review. French.

3

Primary Gleason pattern upgrading in contemporary patients with D'Amico low-risk prostate cancer: implications for future biomarkers and imaging modalities.

Leyh-Bannurah SR, Abou-Haidar H, Dell'Oglio P, Schiffmann J, Tian Z, Heinzer H, Huland H, Graefen M, Budäus L, Karakiewicz PI. Leyh-Bannurah SR, et al. BJU Int. 2017 May;119(5):692-699. doi: 10.1111/bju.13570. Epub 2016 Aug 5. BJU Int. 2017. PMID: 27367469

4

Optimizing D'Amico risk groups in radical prostatectomy through the addition of magnetic resonance imaging data.

Algarra R, Zudaire B, Tienza A, Velis JM, Rincón A, Pascual I, Zudaire J. Algarra R, et al. Actas Urol Esp. 2014 Nov;38(9):594-9. doi: 10.1016/j.acuro.2014.03.003. Epub 2014 May 3. Actas Urol Esp. 2014. PMID: 24791621 English, Spanish.

5

External validation of the UCSF-CAPRA (University of California, San Francisco, Cancer of the Prostate Risk Assessment) in Japanese patients receiving radical prostatectomy.

Ishizaki F, Hoque MA, Nishiyama T, Kawasaki T, Kasahara T, Hara N, Takizawa I, Saito T, Kitamura Y, Akazawa K, Takahashi K. Ishizaki F, et al. Jpn J Clin Oncol. 2011 Nov;41(11):1259-64. doi: 10.1093/jjco/hyr136. Epub 2011 Sep 22. Jpn J Clin Oncol. 2011. PMID: 21940731

6

Inverse stage migration patterns in North American patients undergoing local prostate cancer treatment: a contemporary population-based update in light of the 2012 USPSTF recommendations.

Leyh-Bannurah SR, Karakiewicz PI, Pompe RS, Preisser F, Zaffuto E, Dell'Oglio P, Briganti A, Nafez O, Fisch M, Steuber T, Graefen M, Budäus L. Leyh-Bannurah SR, et al. World J Urol. 2019 Mar;37(3):469-479. doi: 10.1007/s00345-018-2396-2. Epub 2018 Jul 10. World J Urol. 2019. PMID: 29992380

7

Prostate cancer in 432 men aged <50 years in the prostate-specific antigen era: a new outlook.

Gielchinsky I, Chang J, Cusick T, Delprado W, Nguyen Q, Yuen C, Savdie R, Böhm M, Haynes AM, Scheltema MJ, Stricker PD. Gielchinsky I, et al. BJU Int. 2018 Nov;122 Suppl 5:35-41. doi: 10.1111/bju.14586. Epub 2018 Nov 8. BJU Int. 2018. PMID: 30303599

8

[Comparative study of radical prostatectomy versus external beam radiotherapy (75.6 Gy) combined with hormone therapy for prostate cancer of intermediate D'Amico risk classification].

Boissier R, Karsenty G, Muracciole X, Daniel L, Delaporte V, Maurin C, Coulange C, Lechevallier E. Boissier R, et al. Prog Urol. 2013 Sep;23(10):861-8. doi: 10.1016/j.purol.2013.04.007. Epub 2013 May 13. Prog Urol. 2013. PMID: 24034798 French.

9

Identifying the Most Informative Prediction Tool for Cancer-specific Mortality After Radical Prostatectomy: Comparative Analysis of Three Commonly Used Preoperative Prediction Models.

Boehm K, Larcher A, Beyer B, Tian Z, Tilki D, Steuber T, Karakiewicz PI, Heinzer H, Graefen M, Budäus L. Boehm K, et al. Eur Urol. 2016 Jun;69(6):1038-43. doi: 10.1016/j.eururo.2015.07.051. Epub 2015 Aug 10. Eur Urol. 2016. PMID: 26272236

10

Reassessment of the risk factors for biochemical recurrence in D'Amico intermediate-risk prostate cancer treated using radical prostatectomy.

Narita S, Mitsuzuka K, Tsuchiya N, Koie T, Kawamura S, Ohyama C, Tochigi T, Yamaguchi T, Arai Y, Habuchi T; Michinoku Japan Urological Cancer Study Group. Narita S, et al. Int J Urol. 2015 Nov;22(11):1029-35. doi: 10.1111/iju.12898. Epub 2015 Aug 20. Int J Urol. 2015. PMID: 26290306

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

132 results

Results by year